Schaffner F
Yale J Biol Med. 1977 Sep-Oct;50(5):489-95.
Adverse drug reactions in liver involve formation of a reactive metabolic intermediary of the drug, binding of the intermediary to macromolecules in the cell, notably proteins in the plasma membrane, immunological response to these altered proteins and attack against hepatocytes bearing these altered proteins by immune mechanisms. At each step in this complex process many factors act to enhance or depress drug metabolism, metabolite disposition, macromolecular binding, neoantigen formation, and the cell mediated and humoral immune attack. The extent and direction of each step may be dose dependent but the complexity of the overall mechanism is so immense that predictability of hepatic drug reactions is unlikely in most instances.
药物在肝脏中的不良反应涉及药物活性代谢中间体的形成、中间体与细胞内大分子(尤其是质膜中的蛋白质)的结合、对这些改变的蛋白质的免疫反应以及通过免疫机制对携带这些改变蛋白质的肝细胞的攻击。在这个复杂过程的每一步,许多因素都会影响药物代谢、代谢物处置、大分子结合、新抗原形成以及细胞介导和体液免疫攻击的增强或抑制。每一步的程度和方向可能取决于剂量,但整体机制非常复杂,以至于在大多数情况下,肝脏药物反应的可预测性很低。